van Velkinburgh Jennifer Christine, Herbst Mark D, Casper Stewart M
Science Communication, Filipodia Publishing LLC, Santa Fe, NM 87505, United States.
Diagnostic Radiology, Independent Diagnostic Radiology Inc, St Petersburg, FL 33711, United States.
World J Clin Cases. 2023 Jul 6;11(19):4477-4497. doi: 10.12998/wjcc.v11.i19.4477.
Interest and uptake of science and medicine peer-reviewed literature by readers outside of a paper's topical subject, field or even discipline is ever-expanding. While the application of knowledge from one field or discipline to others can stimulate innovative solutions to problems facing modern society, it is also fraught with danger for misuse. In the practice of law in the United States, academic papers are submitted to the courts as evidence in personal injury litigation from both the plaintiff (complainant) and defendant. Such transcendence of an academic publication over disciplinary boundaries is immediately met with the challenge of application by a group that inherently lacks in-depth knowledge on the scientific method, the practice of evidence-based medicine, or the publication process as a structured and internationally synthesized process involving peer review and guided by ethical standards and norms. A modern-day example of this is the ongoing conflict between the sensitivity of diffusion tensor imaging (DTI) and the legal standards for admissibility of evidence in litigation cases of mild traumatic brain injury (mTBI). In this review, we amalgamate the peer-reviewed research on DTI in mTBI with the court's rationale underlying decisions to admit or exclude evidence of DTI abnormalities to support claims of brain injury. We found that the papers which are critical of the use of DTI in the courtroom reflect a primary misunderstanding about how diagnostic biomarkers differ legally from relevant and admissible evidence. The clinical use of DTI to identify white matter abnormalities in the brain at the chronic stage is a valid methodology both clinically as well as forensically, contributes data that may or may not corroborate the existence of white matter damage, and should be admitted into evidence in personal injury trials if supported by a clinician. We also delve into an aspect of science publication and peer review that can be manipulated by scientists and clinicians to publish an opinion piece and misrepresent it as an unbiased, evidence-based, systematic research article in court cases, the decisions of which establish precedence for future cases and have implications on future legislation that will impact the lives of every citizen and erode the integrity of science and medicine practitioners.
论文主题、领域甚至学科之外的读者对科学和医学同行评审文献的兴趣及接受度正在不断扩大。虽然将一个领域或学科的知识应用于其他领域可以激发解决现代社会面临问题的创新方案,但这也存在被滥用的风险。在美国的法律实践中,学术论文会被原告(申诉人)和被告提交给法庭,作为人身伤害诉讼的证据。学术出版物跨越学科界限的这种情况,立即面临着一个固有问题的挑战,即该群体对科学方法、循证医学实践或作为一个涉及同行评审并受道德标准和规范指导的结构化国际综合过程的出版过程缺乏深入了解。一个当代的例子是,弥散张量成像(DTI)的敏感性与轻度创伤性脑损伤(mTBI)诉讼案件中证据可采性的法律标准之间正在持续存在冲突。在本综述中,我们将mTBI中DTI的同行评审研究与法庭决定采纳或排除DTI异常证据以支持脑损伤索赔的基本原理进行了整合。我们发现,那些批评在法庭上使用DTI的论文反映了对诊断生物标志物在法律上与相关且可采证据的差异存在主要误解。DTI在临床和法医上用于识别慢性期脑白质异常的临床应用是一种有效的方法,它提供的数据可能证实也可能不证实白质损伤的存在,如果有临床医生支持,应在人身伤害审判中被采纳为证据。我们还深入探讨了科学出版和同行评审的一个方面,科学家和临床医生可能会操纵这一方面,在法庭案件中发表一篇观点文章并将其歪曲为无偏见的、循证的、系统的研究文章,而法庭的这些决定会为未来的案件确立先例,并对未来的立法产生影响,这将影响每个公民的生活,并侵蚀科学和医学从业者的诚信。